These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33205975)

  • 21. Use of small-molecule crystal structures to address solubility in a novel series of G protein coupled receptor 119 agonists: optimization of a lead and in vivo evaluation.
    Scott JS; Birch AM; Brocklehurst KJ; Broo A; Brown HS; Butlin RJ; Clarke DS; Davidsson O; Ertan A; Goldberg K; Groombridge SD; Hudson JA; Laber D; Leach AG; Macfaul PA; McKerrecher D; Pickup A; Schofield P; Svensson PH; Sörme P; Teague J
    J Med Chem; 2012 Jun; 55(11):5361-79. PubMed ID: 22545772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of a Potent, Selective, and Brain-Penetrant Small Molecule that Activates the Orphan Receptor GPR88 and Reduces Alcohol Intake.
    Jin C; Decker AM; Makhijani VH; Besheer J; Darcq E; Kieffer BL; Maitra R
    J Med Chem; 2018 Aug; 61(15):6748-6758. PubMed ID: 30011199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery and optimization of a novel series of N-arylamide oxadiazoles as potent, highly selective and orally bioavailable cannabinoid receptor 2 (CB2) agonists.
    Cheng Y; Albrecht BK; Brown J; Buchanan JL; Buckner WH; DiMauro EF; Emkey R; Fremeau RT; Harmange JC; Hoffman BJ; Huang L; Huang M; Lee JH; Lin FF; Martin MW; Nguyen HQ; Patel VF; Tomlinson SA; White RD; Xia X; Hitchcock SA
    J Med Chem; 2008 Aug; 51(16):5019-34. PubMed ID: 18680277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacophore-based design of novel oxadiazoles as selective sphingosine-1-phosphate (S1P) receptor agonists with in vivo efficacy.
    Quattropani A; Sauer WH; Crosignani S; Dorbais J; Gerber P; Gonzalez J; Marin D; Muzerelle M; Beltran F; Nichols A; Georgi K; Schneider M; Vitte PA; Eligert V; Novo-Perez L; Hantson J; Nock S; Carboni S; de Souza AL; Arrighi JF; Boschert U; Bombrun A
    ChemMedChem; 2015 Apr; 10(4):688-714. PubMed ID: 25735812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The discovery of potent agonists for GPR88, an orphan GPCR, for the potential treatment of CNS disorders.
    Bi Y; Dzierba CD; Fink C; Garcia Y; Green M; Han J; Kwon S; Kumi G; Liang Z; Liu Y; Qiao Y; Zhang Y; Zipp G; Burford N; Ferrante M; Bertekap R; Lewis M; Cacace A; Westphal RS; Kimball D; Bronson JJ; Macor JE
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1443-7. PubMed ID: 25754495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural modifications of N-arylamide oxadiazoles: Identification of N-arylpiperidine oxadiazoles as potent and selective agonists of CB2.
    DiMauro EF; Buchanan JL; Cheng A; Emkey R; Hitchcock SA; Huang L; Huang MY; Janosky B; Lee JH; Li X; Martin MW; Tomlinson SA; White RD; Zheng XM; Patel VF; Fremeau RT
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4267-74. PubMed ID: 18640038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rational design, synthesis and biological evaluation of 1,3,4-oxadiazole pyrimidine derivatives as novel pyruvate dehydrogenase complex E1 inhibitors.
    He H; Wang W; Zhou Y; Xia Q; Ren Y; Feng J; Peng H; He H; Feng L
    Bioorg Med Chem; 2016 Apr; 24(8):1879-88. PubMed ID: 26972920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The orphan receptor GPR88 blunts the signaling of opioid receptors and multiple striatal GPCRs.
    Laboute T; Gandía J; Pellissier LP; Corde Y; Rebeillard F; Gallo M; Gauthier C; Léauté A; Diaz J; Poupon A; Kieffer BL; Le Merrer J; Becker JA
    Elife; 2020 Jan; 9():. PubMed ID: 32003745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Orphan Receptor GPR88 as an Emerging Neurotherapeutic Target.
    Ye N; Li B; Mao Q; Wold EA; Tian S; Allen JA; Zhou J
    ACS Chem Neurosci; 2019 Jan; 10(1):190-200. PubMed ID: 30540906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping GPR88-Venus illuminates a novel role for GPR88 in sensory processing.
    Ehrlich AT; Semache M; Bailly J; Wojcik S; Arefin TM; Colley C; Le Gouill C; Gross F; Lukasheva V; Hogue M; Darcq E; Harsan LA; Bouvier M; Kieffer BL
    Brain Struct Funct; 2018 Apr; 223(3):1275-1296. PubMed ID: 29110094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and synthesis of new 2-substituted-5-(2-benzylthiophenyl)-1,3,4-oxadiazoles as benzodiazepine receptor agonists.
    Zarghi A; Faizi M; Shafaghi B; Ahadian A; Khojastehpoor HR; Zanganeh V; Tabatabai SA; Shafiee A
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3126-9. PubMed ID: 15876530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and synthesis of 1-(1-benzothiophen-7-yl)-1H-pyrazole, a novel series of G protein-coupled receptor 52 (GPR52) agonists.
    Nakahata T; Tokumaru K; Ito Y; Ishii N; Setoh M; Shimizu Y; Harasawa T; Aoyama K; Hamada T; Kori M; Aso K
    Bioorg Med Chem; 2018 May; 26(8):1598-1608. PubMed ID: 29478803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery and optimization of new oxadiazole substituted thiazole RORγt inverse agonists through a bioisosteric amide replacement approach.
    Steeneck C; Gege C; Kinzel O; Albers M; Kleymann G; Schlüter T; Schulz A; Xue X; Cummings MD; Fourie AM; Leonard KA; Scott B; Edwards JP; Hoffmann T; Goldberg SD
    Bioorg Med Chem Lett; 2020 Jun; 30(12):127174. PubMed ID: 32334912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GPR88 in A
    Meirsman AC; de Kerchove d'Exaerde A; Kieffer BL; Ouagazzal AM
    Eur J Neurosci; 2017 Aug; 46(4):2026-2034. PubMed ID: 28700108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, modelling studies and biological evaluation of 1,3,4-oxadiazole derivatives as potent anticancer agents targeting thymidine phosphorylase enzyme.
    Bajaj S; Kumar MS; Tinwala H; Yc M
    Bioorg Chem; 2021 Jun; 111():104873. PubMed ID: 33845381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rationale Design, Synthesis, Cytotoxicity Evaluation, and Molecular Docking Studies of 1,3,4-oxadiazole Analogues.
    Ahsan MJ; Choupra A; Sharma RK; Jadav SS; Padmaja P; Hassan MZ; Al-Tamimi ABS; Geesi MH; Bakht MA
    Anticancer Agents Med Chem; 2018; 18(1):121-138. PubMed ID: 28425854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The GPR88 receptor agonist 2-PCCA does not alter the behavioral effects of methamphetamine in rats.
    Li JX; Thorn DA; Jin C
    Eur J Pharmacol; 2013 Jan; 698(1-3):272-7. PubMed ID: 23123351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and antiviral activity of 2-substituted methylthio-5-(4-amino-2-methylpyrimidin-5-yl)-1,3,4-oxadiazole derivatives.
    Wu W; Chen Q; Tai A; Jiang G; Ouyang G
    Bioorg Med Chem Lett; 2015; 25(10):2243-6. PubMed ID: 25900217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The GPR88 agonist RTI-13951-33 reduces alcohol drinking and seeking in mice.
    Ben Hamida S; Carter M; Darcq E; Sourty M; Rahman MT; Decker AM; Jin C; Kieffer BL
    Addict Biol; 2022 Nov; 27(6):e13227. PubMed ID: 36301207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Orphan receptor GPR88 as a potential therapeutic target for CNS disorders - an
    Garisetti V; Dhanabalan AK; Dasararaju G
    J Biomol Struct Dyn; 2024 Jun; 42(9):4745-4758. PubMed ID: 37306437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.